600211.SS · 西藏药业
China A-shares · RS rating 49 · As of 2026-10-14
| Price | 36.71 CNY |
|---|---|
| 1-day change | -0.3% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 59 / 48 / 28 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 15 / 22 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +14.8% |
| Distance from 52-week high | +25.4% |
| Market cap (USD) | $1.7B |